Regardless, I hope you will share with us the source material on which you base your conclusion that 1 capsule of generic IPE contains the same quantity of purified eicosapent ethyl ester as does 1, 1 gram capsule of Vascepa.

 

Amarin would probably be interested in seeing that material, as well.

 

Also, are you contending that CEO Thero is incorrect in stating that the FDA's equivalence rating of AB for Hikma's generic IPE applies to only the severe hypertriglyceridemia indication?  If you are, please share the sources supporting such a position.